US$ 22.38
novo glp-1 drug Nordisk launches its Wegovy Pill weight-loss to the US market, GoodRx discounts it More than a third of
Description
Low-income beneficiaries may also face higher costs than they would under normal Part D protections

This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva's diverse complex generics portfolio, demonstrating once again our proven ability to sustain a world-class Generics Powerhouse, said Richardsen

That percentage is even higher among women ages 50 to 64, where 20% of that population has taken a GLP-1 agonist drug

Week 5-12: titration phase For lupus patients, consider extending to 6-8 weeks at each dose level instead of the standard 4 weeks
Fuselier et al., 2022)
